PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 61-77 of 77

    November 20, 2012 Drug Alert: Important Drug Warning

    XELJANZ® (tofacitinib)

    Pfizer Inc

    November 20, 2012 Drug Approval:

    Lyrica (pregabalin)

    Pfizer Pharmaceuticals LLC

    October 23, 2012 Drug Alert: Important Prescribing Information

    ACTEMRA® (tocilizumab)

    Genentech

    October 01, 2012 Drug Alert: Important Safety Information

    BONIVA® Injection (ibandronate sodium)

    Genentech

    August 16, 2012 Drug Alert: Important Drug Warning

    Qualaquin® (quinine sulfate)

    URL Pharma Inc.

    August 01, 2012 Drug Alert: Important Drug Warning

    Bydureon(TM) (exenatide extended-release for injectable suspension)

    Amylin

    July 24, 2012 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    July 19, 2012 Drug Alert: Important Drug Warning

    BRILINTA (TM) (ticagrelor)

    AstraZeneca

    June 12, 2012 Drug Approval:

    RECTIV(TM) (nitroglycerin)

    Aptalis

    May 07, 2012 Drug Alert: Important Drug Warning

    XENICAL® (orlistat)

    Genentech

    February 29, 2012 Drug Alert: Important Drug Warning

    AVASTIN® (bevacizumab)

    Genentech

    February 01, 2012 Drug Alert: Important Drug Warning

    Bydureon(TM) (exenatide extended-release for injectable suspension)

    Amylin

    January 23, 2012 Drug Alert: Important Prescribing Information

    AVASTIN® (bevacizumab)

    Genentech

    January 20, 2012 Drug Alert: Important Drug Warning

    BRILINTA (TM) (ticagrelor)

    AstraZeneca

    January 19, 2012 Drug Alert: Important Drug Warning

    ADCETRIS(TM) (brentuximab vedotin)

    Seattle Genetics, Inc.

    January 05, 2012 Drug Approval:

    Eylea(TM)

    Regeneron

    January 05, 2012 Drug Alert: Important Drug Warning

    ARCAPTA(TM) NEOHALER(TM) (indacaterol inhalation powder)

    Novartis Pharmaceuticals Corporation

    Results 61-77 of 77